TY - JOUR
T1 - Inflammatory markers in STelevation acute myocardial infarction
AU - Seropian, Ignacio M.
AU - Sonnino, Chiara
AU - Van Tassell, Benjamin W.
AU - Biasucci, Luigi Marzio
AU - Abbate, Antonio
PY - 2016
Y1 - 2016
N2 - After acute myocardial infarction, ventricular remodeling is characterized by changes at the molecular, structural, geometrical and functional level that determine progression to heart failure. Inflammation plays a key role in wound healing and scar formation, affecting ventricular remodeling. Several, rather different, components of the inflammatory response were studied as biomarkers in ST-elevation acute myocardial infarction. Widely available and inexpensive tests, such as leukocyte count at admission, as well as more sophisticated immunoassays provide powerful predictors of adverse outcome in patients with ST-elevation acute myocardial infarction. We review the value of inflammatory markers in ST-elevation acute myocardial infarction and their association with ventricular remodeling, heart failure and sudden death. In conclusion, the use of these biomarkers may identify subjects at greater risk of adverse events and perhaps provide an insight into the mechanisms of disease progression.
AB - After acute myocardial infarction, ventricular remodeling is characterized by changes at the molecular, structural, geometrical and functional level that determine progression to heart failure. Inflammation plays a key role in wound healing and scar formation, affecting ventricular remodeling. Several, rather different, components of the inflammatory response were studied as biomarkers in ST-elevation acute myocardial infarction. Widely available and inexpensive tests, such as leukocyte count at admission, as well as more sophisticated immunoassays provide powerful predictors of adverse outcome in patients with ST-elevation acute myocardial infarction. We review the value of inflammatory markers in ST-elevation acute myocardial infarction and their association with ventricular remodeling, heart failure and sudden death. In conclusion, the use of these biomarkers may identify subjects at greater risk of adverse events and perhaps provide an insight into the mechanisms of disease progression.
KW - Biological markers
KW - Biomarkers
KW - Chemokines
KW - Cytokines
KW - Humans
KW - Inflammation
KW - Leukocyte Count
KW - Medicine (all)
KW - Prognosis
KW - ST Elevation Myocardial Infarction
KW - ST-elevation acute myocardial infarction
KW - Ventricular Remodeling
KW - Ventricular remodeling
KW - Biological markers
KW - Biomarkers
KW - Chemokines
KW - Cytokines
KW - Humans
KW - Inflammation
KW - Leukocyte Count
KW - Medicine (all)
KW - Prognosis
KW - ST Elevation Myocardial Infarction
KW - ST-elevation acute myocardial infarction
KW - Ventricular Remodeling
KW - Ventricular remodeling
UR - http://hdl.handle.net/10807/122907
UR - http://acc.sagepub.com/
U2 - 10.1177/2048872615568965
DO - 10.1177/2048872615568965
M3 - Article
SN - 2048-8726
VL - 5
SP - 382
EP - 395
JO - EUROPEAN HEART JOURNAL. ACUTE CARDIOVASCULAR CARE
JF - EUROPEAN HEART JOURNAL. ACUTE CARDIOVASCULAR CARE
ER -